UK testing 'world first' vaccine for norovirus vomiting bug, aiming to curb burden on health system
The late-stage trial will recruit about 25,000 people around the world to test the new vaccine from Moderna.View on euronews
World-first vaccine for vomiting bug norovirus trialled in the UK
The jab uses mRNA technology to tell the immune system to recognise a ‘foreign’ protein on viruses and mount an attack.
What we know about the norovirus vaccine
We hate to say it, but norovirus season has arrived. The winter vomiting bug is notorious for being highly contagious and can put people out of commission for between one to three days. The number of people who catch norovirus each year in the UK is astronomically high - as many as four million people are struck down by it annually.
What is the norovirus vaccine as trials start in the UK?
A new vaccine against the winter vomiting bug, norovirus, is being tested on volunteers after preliminary findings indicated the injection elicited a “strong immune response”.
Norovirus vaccine trial to launch in the UK
A randomised clinical trial of an mRNA vaccine against norovirus will be launched in the UK within the next two weeks, it has been announced.
Norovirus vaccine to be trialled in the UK in world-first
A trial in the UK will see a norovirus given to patients with the Health Secretary hoping it will cut the “burden on the NHS”.
How world’s first norovirus vaccine could keep thousands out of hospital
A vaccine for the vomiting bug norovirus is being trialled in the UK for the first time, with the hope it could cut the “burden on the NHS”, the Health Secretary has said. The new mRNA vaccine from Moderna will enter final stages of testing within the next two weeks,
World-first norovirus vaccine trialled in UK hospitals
A first-of-its-kind vaccine against the vomit bug norovirus is being trialled in the UK, using the same tech employed in the Covid jab. Thousands of Brits end up in hospital every year due to the highly contagious virus,
IDWeek 2024: Moderna’s norovirus vaccine mRNA-1403 shows potential in Phase I/II trial
As one of the leading causes of acute gastroenteritis worldwide, NoV is associated with a substantial healthcare burden.
Newcastle's Royal Victoria Infirmary to take part in UK's first-ever norovirus mRNA vaccine trial
The trial will evaluate the efficacy, safety, and immunogenicity of an investigational norovirus vaccine, mRNA-1403 ...
Sky18h
British volunteers sought for trial of vaccine to protect against norovirus
Every year norovirus is linked to around 12,000 hospital admissions in the UK and about 80 deaths. Experts believe a new ...
What would the norovirus vaccines mean for NHS pressure and wait times?
This isn’t just about patients getting ill. A vaccine could also help prevent healthcare staff absences, with current NHS ...
Business Insider23d
Moderna Announces First Participant Dosed in Pivotal Phase 3 Trial of Investigational mRNA Norovirus Vaccine, mRNA-1403
2 mRNA-1403 is an mRNA vaccine in development to prevent moderate to severe acute gastroenteritis caused by norovirus. The vaccine candidate is a trivalent formulation containing mRNA that ...